Growth Metrics

Zymeworks (ZYME) Cash & Current Investments (2021 - 2025)

Zymeworks' Cash & Current Investments history spans 5 years, with the latest figure at $228.8 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 1.34% to $228.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $228.8 million, a 1.34% increase, with the full-year FY2025 number at $228.8 million, up 1.34% from a year prior.
  • Cash & Current Investments hit $228.8 million in Q4 2025 for Zymeworks, down from $251.9 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for ZYME hit a ceiling of $492.2 million in Q4 2022 and a floor of $166.2 million in Q3 2022.
  • Historically, Cash & Current Investments has averaged $299.2 million across 5 years, with a median of $295.4 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: soared 94.86% in 2022 and later tumbled 39.68% in 2024.
  • Tracing ZYME's Cash & Current Investments over 5 years: stood at $252.6 million in 2021, then soared by 94.86% to $492.2 million in 2022, then dropped by 23.95% to $374.3 million in 2023, then tumbled by 39.68% to $225.8 million in 2024, then rose by 1.34% to $228.8 million in 2025.
  • Business Quant data shows Cash & Current Investments for ZYME at $228.8 million in Q4 2025, $251.9 million in Q3 2025, and $281.4 million in Q2 2025.